|
CCDC55 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.427200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.909980E-01 |
| Normal-vs-Stage2 |
7.365400E-01 |
| Normal-vs-Stage3 |
1.105970E-01 |
| Normal-vs-Stage4 |
7.434000E-02 |
| Stage1-vs-Stage2 |
2.581400E-01 |
| Stage1-vs-Stage3 |
2.379900E-03 |
| Stage1-vs-Stage4 |
2.760100E-03 |
| Stage2-vs-Stage3 |
4.842000E-01 |
| Stage2-vs-Stage4 |
3.749200E-01 |
| Stage3-vs-Stage4 |
7.632600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.886000E-01 |
| Normal-vs-AfricanAmerican |
5.205800E-01 |
| Normal-vs-Asian |
8.038200E-02 |
| Caucasian-vs-AfricanAmerican |
5.790600E-01 |
| Caucasian-vs-Asian |
1.438370E-01 |
| AfricanAmerican-vs-Asian |
1.317980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.619800E-01 |
| Normal-vs-Female |
1.693410E-01 |
| Male-vs-Female |
3.438800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.081400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.686800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.884000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.239400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.328600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.966200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.493800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.575800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.968760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.592600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.394500E-04 |
| Normal-vs-Grade 2 |
9.166200E-02 |
| Normal-vs-Grade 3 |
9.883800E-02 |
| Normal-vs-Grade 4 |
2.907900E-02 |
| Grade 1-vs-Grade 2 |
4.916400E-02 |
| Grade 1-vs-Grade 3 |
1.846260E-04 |
| Grade 1-vs-Grade 4 |
1.245880E-04 |
| Grade 2-vs-Grade 3 |
1.398830E-04 |
| Grade 2-vs-Grade 4 |
4.563300E-04 |
| Grade 3-vs-Grade 4 |
3.111200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.389300E-04 |
| Normal-vs-ccB subtype |
1.566330E-02 |
| ccA subtype-vs-ccB subtype |
2.68310040851816E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.324600E-01 |
| Normal-vs-N1 |
3.189200E-01 |
| N0-vs-N1 |
4.907400E-01 |
|
|
